Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IM Vitamin D2 and D3 for Vitamin D Deficiency
NCT06618365Active, not recruiting
- Sponsor
- Hamad Medical Corporation
- Start
- Feb 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (4 arms), sponsored by Hamad Medical Corporation. Primary endpoint: Percentage of patients attaining Vitamin D levels >30ng/ml at 3 months. Started Feb 2023; status: active, not recruiting.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT06618365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618365.